Skip to main content
    S

    Sol Gel Technologies Ltd (SLGL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $54.96
    -0.16 (-0.29%)

    Market Cap: $180.46M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sol Gel Technologies Ltd (SLGL) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sol Gel Technologies (SLGL) trades at 125.4x sales and 4.2x book value. Its P/S of 125.4x is above its 5-year median of 13.5x. Its forward P/E is 9.3x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E9.3x
    Price to sales125.4x
    Price to book4.2x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 50.0% above 2.8x.

    MultipleCurrent5-year median10-year median
    P/S125.4x13.5xN/A
    P/B4.2x2.4x2.8x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 104 months (10-year).

    Valuation History

    Over the 8 year ends shown, its P/S ranged from 2.2x in 2024 to 801.0x in 2018.

    Year endPriceP/EP/SP/B
    2025$42.1454.7x6.4x5.1x
    2024$9.3025.8x2.2x0.9x
    2023$11.05N/A14.6x0.8x
    2022$45.60N/A27.8x25.0x
    2021$74.00N/A13.9x31.5x
    2020$97.90N/A31.3x44.3x
    2019$171.50N/A24.4x69.8x
    2018$60.20N/A801.0x1.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About SLGL

    What is SLGL's forward P/E ratio?

    Sol Gel Technologies has a forward P/E ratio of 9.3x.

    What is SLGL's price to sales ratio?

    Sol Gel Technologies has a price to sales ratio of 125.4x.